Which hedge funds own RARXEUR? RA PHARMACEUTICALS INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in RARXEUR (RA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q2 2020 | 0 | 68 | 0.0% | $0 |
| Q1 2020 | 5 | 68 | 7.4% | $377m |
| Q4 2019 | 4 | 67 | 6.0% | $309m |
| Q3 2019 | 2 | 60 | 3.3% | $124m |
| Q2 2019 | 2 | 60 | 3.3% | $155m |
| Q1 2019 | 3 | 60 | 5.0% | $120m |
| Q4 2018 | 3 | 60 | 5.0% | $38.5m |
| Q3 2018 | 3 | 59 | 5.1% | $73.7m |
| Q2 2018 | 2 | 59 | 3.4% | $39.0m |
| Q1 2018 | 2 | 59 | 3.4% | $21.4m |
| Q4 2017 | 2 | 59 | 3.4% | $12.3m |
| Q3 2017 | 1 | 56 | 1.8% | $19.7m |
| Q2 2017 | 1 | 56 | 1.8% | $25.3m |
| Q1 2017 | 1 | 56 | 1.8% | $28.8m |
| Q4 2016 | 1 | 56 | 1.8% | $20.5m |
Who discovered RARXEUR first?
Earliest meaningful positions among the 6 tracked managers seen opening RARXEUR since Q4 2016.
| RA Capital Management, L.P. high conviction | Q4 2016 | 2.9% | Exited by Q2 2020 | +216% |
| Pentwater Capital Management LP | Q4 2019 | 0.3% | Exited by Q2 2020 | +2.3% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.